Nasdaq News

The cost-cutting effort is likely a restructuring rather than a reduction.

The healthcare industry is ripe for disruption.

Cotton futures saw slight strength on Monday, with contracts up 1 to 19 points at the close. Crude oil was up $1.74 per barrel on the session, with the US dollar index $0.142 higher. The weekly Crop Progress report showed 85% of the US cotton crop with bolls opening as...

Corn futures were disappointed in a 2 year low in export shipments, as contracts were down 1 ¼ to 7 ¼ cents across the board. The CmdtyView national average Cash Corn price was 7 1/4 lower cents at $4.27 1/4. USDA’s Export Inspections report tallied corn export shipments at just...

The Latin American economy has greater growth prospects than most of the developed world.

The proliferation of agentic AI has been great news for Shopify (NASDAQ: SHOP) stock investors.

For decades, Costco (NASDAQ: COST) has offered its customers an excellent value proposition.

The delay of the Neutron launch has huge implications for investors.

Nebius (NASDAQ: NBIS) must invest billions to capture its opportunity in AI.

Investors are growing concerned about Applied Digital's (NASDAQ: APLD) large cash needs.

The home improvement industry is struggling for growth in 2026.

Nike's (NYSE: NKE) stock is trading near 52-week lows.

Investors are questioning the unit economics of this industry.

Higher interest rates are putting pressure on CoreWeave (NASDAQ: CRWV).

Key PointsCoreWeave's stock has plunged on concerns about rising yields on its bonds.

The wheat complex posted losses across the three exchanges on Monday. Chicago SRW contracts were 2 ¼ to 5 cents in the red at the close. KC HRW futures were fractionally to 4 ½ cents lower on Monday. MPLS spring wheat was down 3 3/4 to 6 3/4 cents at...

Key PointsOver a billion of SpaceX’s shares will become eligible for sale after the company’s third-quarter update.

Key PointsCracker Barrel's fiscal fourth-quarter adjusted earnings of $0.99 a share easily beat Wall Street's $0.17 estimate.

(RTTNews) - IDEAYA Biosciences Inc. (IDYA), a precision medicine oncology company, on Monday released updated clinical data on three trials evaluating Darovasertib in treating metastatic and primary uveal melanoma (UM).

Fintel reports that on October 19, 2026, JP Morgan upgraded their outlook for Intel (NASDAQGS:INTC) (BATS-CHIXE:INLD) from Underweight to Neutral.This rating action follows a prior action by JP Morgan on July 24, 2026, where the firm maintained its Underweight rating on the stock